Nephros (NEPH) Current Assets (2010 - 2026)

Nephros' Current Assets history runs 17 years deep, the most recent figure standing at $11.5 million for Q1 2026.

• On a quarterly basis, Current Assets rose 27.85% year-over-year to $11.5 million in Q1 2026; TTM through Mar 2026 was $11.5 million, a 27.85% increase from a year earlier, with the FY2025 full-year figure at $11.2 million, up 35.25% from the prior year.
• Current Assets climbed to $11.5 million in Q1 2026 per NEPH's latest filing, from $11.2 million in the prior quarter.
• Across five years, Current Assets topped out at $11.7 million in Q1 2022 and bottomed at $7.4 million in Q3 2024.
• The 5-year median for Current Assets is $8.5 million (2023), against an average of $9.2 million.
• Across the five-year window, Current Assets sank 39.41% in 2022 and surged 45.54% in 2025, its largest moves.
• Year by year, Current Assets stood at $8.3 million in 2022, then gained by 1.74% to $8.4 million in 2023, then decreased by 1.27% to $8.3 million in 2024, then soared by 35.25% to $11.2 million in 2025, then climbed by 2.43% to $11.5 million in 2026.
• Per Business Quant, the three latest NEPH Current Assets figures stand at $11.5 million (Q1 2026), $11.2 million (Q4 2025), and $10.7 million (Q3 2025).